These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

704 related items for PubMed ID: 11488259

  • 1. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B, Bonnet-Perrin E.
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [Abstract] [Full Text] [Related]

  • 2. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
    Tollefson GD, Birkett M, Koran L, Genduso L.
    J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
    [Abstract] [Full Text] [Related]

  • 3. Predictors of drug treatment response in obsessive-compulsive disorder.
    Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G.
    J Clin Psychiatry; 1995 Aug; 56(8):368-73. PubMed ID: 7635854
    [Abstract] [Full Text] [Related]

  • 4. [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].
    Hantouche EG, Bouhassira M, Lancrenon S.
    Encephale; 2000 Aug; 26(6):73-83. PubMed ID: 11217541
    [Abstract] [Full Text] [Related]

  • 5. [Psychosurgical treatment of malignant OCD: three case-reports].
    Polosan M, Millet B, Bougerol T, Olié JP, Devaux B.
    Encephale; 2003 Aug; 29(6):545-52. PubMed ID: 15029089
    [Abstract] [Full Text] [Related]

  • 6. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E, Mullen L, DeCaria CM, Skodol A, Schneier FR, Liebowitz MR, Klein DF.
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [Abstract] [Full Text] [Related]

  • 7. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ.
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
    [Abstract] [Full Text] [Related]

  • 8. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG, Thatte S, Wiggins D.
    Psychopharmacol Bull; 1990 Nov; 26(3):285-90. PubMed ID: 2274627
    [Abstract] [Full Text] [Related]

  • 9. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial.
    Liebowitz MR, Hollander E, Schneier F, Campeas R, Hatterer J, Papp L, Fairbanks J, Sandberg D, Davies S, Stein M.
    J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of long-term fluoxetine treatment of obsessive-compulsive disorder.
    Frenkel A, Rosenthal J, Nezu A, Winston A.
    Mt Sinai J Med; 1990 Nov; 57(6):348-52. PubMed ID: 2079952
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [Abstract] [Full Text] [Related]

  • 12. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience.
    Riddle MA, Hardin MT, King R, Scahill L, Woolston JL.
    J Am Acad Child Adolesc Psychiatry; 1990 Jan; 29(1):45-8. PubMed ID: 2295577
    [Abstract] [Full Text] [Related]

  • 13. Obsessive-compulsive disorder.
    George MS.
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():57-66; discussion 66-8. PubMed ID: 1806635
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy assessment of fluoxetine treatment of outpatients with obsessive-compulsive disorder: a preliminary report].
    Wandzel L.
    Psychiatr Pol; 1997 Dec; 31(4):429-35. PubMed ID: 9527686
    [Abstract] [Full Text] [Related]

  • 15. Treatment strategies for obsessive-compulsive disorder.
    Marazziti D, Consoli G.
    Expert Opin Pharmacother; 2010 Feb; 11(3):331-43. PubMed ID: 20102301
    [Abstract] [Full Text] [Related]

  • 16. An integrated approach to treatment of obsessive compulsive disorder.
    Greist JH.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963
    [Abstract] [Full Text] [Related]

  • 17. High-dose escitalopram for the treatment of obsessive-compulsive disorder.
    Rabinowitz I, Baruch Y, Barak Y.
    Int Clin Psychopharmacol; 2008 Jan; 23(1):49-53. PubMed ID: 18090508
    [Abstract] [Full Text] [Related]

  • 18. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
    DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S.
    Psychopharmacol Bull; 1990 Jan; 26(1):54-9. PubMed ID: 2196627
    [Abstract] [Full Text] [Related]

  • 19. Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine.
    Mundo E, Rouillon F, Figuera ML, Stigler M.
    Hum Psychopharmacol; 2001 Aug; 16(6):461-468. PubMed ID: 12404554
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M, Pini S, Bellantuono C, Wilkinson G.
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.